Accéder au contenu
Merck

Inhibition effect of enteropeptidase on RANKL-RANK signalling by cleavage of RANK.

FEBS letters (2013-08-21)
Yunfeng Zhao, Mengmeng Jin, Juan Ma, Shiqian Zhang, Wei Li, Yuan Chen, Yingsheng Zhou, Hong Tao, Yu Liu, Lei Wang, Huamin Han, Ge Niu, Hua Tao, Changzhen Liu, Bin Gao
RÉSUMÉ

Enteropeptidase can cleave trypsinogen on the sequence of Asp-Asp-Asp-Asp-Lys and plays an important role in food digestion. The RANKL-RANK signalling pathway plays a pivotal role in bone remodelling. In this study, we reported that enteropeptidase can inhibit the RANKL-RANK signalling pathway through the cleavage of RANK. A surrogate peptide blocking assay indicated that enteropeptidase could specifically cleave RANK on the sequence NEEDK. Osteoclast differentiation assay and NF-κB activity assay confirmed that enteropeptidase could inhibit osteoclastogenesis in vitro through the cleavage of RANK. This is the first study to prove that the RANKL-RANK signalling pathway can be inhibited by cleavage of RANK instead of targeting RANKL.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Enterokinase from bovine intestine, powder
Sigma-Aldrich
Enterokinase from porcine intestine, ≥0.5 units/mg solid
Sigma-Aldrich
Enterokinase from porcine intestine, lyophilized powder, ≥100 units/mg protein